Clinical Trials in Pennsylvania

Showing 13041-13060 of 16,895 trials

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

NCT01043523

Medical records are reviewed to obtain information about the use of a MRI diagnostic imaging agent (contrast agent) called Primovist/Eovist in children older than 2 months and less than 18 years. Data that has been recorded in the child's medical records relating to the injection of Primovist/Eovist will be collected. Information will be collected from up to 2 weeks before the child received Primovist/Eovist until 12 months after the child received Primovist/Eovist. Copy of the child's MR images that were taken right before and after the child received Primovist/Eovist and all other reports (laboratory reports, other imaging reports, etc) that are part of the child's medical records during that time period will be collected.

Liver NeoplasmsAdenomaCarcinoma+1 more

Bayer52 participantsStarted Dec 2009

Palo Alto, California, United States • New York, New York, United States • Durham, North Carolina, United States +6 more locations

COMPLETEDNA61 miles

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

NCT02117414

The purpose of the Evera MRI™ study is to confirm safety and efficacy of the Evera MRI ICD (Implantable cardioverter-defibrillator) System in the clinical MRI (Magnetic Resonance Imaging) environment when subjects receive MRI scans without positioning restrictions (MRI scans may occur anywhere on the body).

Implantable Defibrillator

Medtronic Cardiac Rhythm and Heart Failure275 participantsStarted Apr 2014

Salinas, California, United States • Stanford, California, United States • Hartford, Connecticut, United States +39 more locations

Liver MRI With Primovist/Eovist in Pediatric Subjects Who Are Suspected or Have Focal Liver Lesions.

Confirmatory Clinical Trial of the Evera MRI System for Conditionally-safe MRI Access

Find Trials by Condition in Pennsylvania

Pradaxa Study in Non-valvular Atrial Fibrillation Patients With Severely Impaired Renal Function

Docetaxel+Oxali+/-Cetux Met Gastric/GEJ

Tipranavir Expanded Access Program (EAP) in PI-experienced Patients With HIV-1 Infection

A Study to Evaluate Tolerability of Two Topical Drug Products in the Treatment of Facial Acne

Investigation of the Efficacy and Safety of Concomitant Administration of Ciclesonide Nasal Spray and Azelastine Nasal Spray in Patients (18 Years or Older) With Perennial Allergic Rhinitis (PAR) Not Adequately Controlled on an Intranasal Corticosteroid or Antihistamine Monotherapy (BY9010/M1-490)

Efficacy and Safety of Ledipasvir/Sofosbuvir Fixed-Dose Combination and Sofosbuvir + Ribavirin for Subjects With Chronic Hepatitis C Virus (HCV) and Inherited Bleeding Disorders

Study Evaluating LAMICTAL Extended-Release Therapy Added To Current Seizure Treatments In Patients With Partial Seizures

Using Stories to Address Disparities in Hypertension

Using Technology to Promote Mental Acuity

Prediction of the Efficacy of Activated Recombinant Human Factor VII in Adult Congenital Haemophilia A or B Patients With Inhibitors by Use of Thromboelastography

Assessment of Catheter-based Interrogation and Standard Techniques for Fractional Flow Reserve Measurement

Airway Microbiome in Asthma: Relationships to Asthma Phenotype and Inhaled Corticosteroid Treatment

Wound Fluid Protease Levels During Use of Novel Wound Dressing

Pharmacodynamic Study of the Effect of INCB013739 on Insulin Sensitivity in Obese, Type 2 Diabetic Subjects

Trial of Clindamycin / Benzoyl Peroxide Gel in Subjects With Acne

An Open Label Safety Study of Tipranavir Co-administered With Low-dose Ritonavir in Patients With Advanced HIV-1 Infection and Limited Treatment Options.

Efficacy and Safety of Ciclesonide Administered With or Without Different Spacers in Patients With Asthma (12 to 75 y) (BY9010/M1-145)

Efficacy of Ciclesonide vs Fixed Combination of Fluticasone Propionate/Salmeterol vs Placebo in Patients With Mild Persistent Asthma (12 to 75 y) (BY9010/M1-132)